Next, EGFR and ERBB2/HER2 protein expression was evaluated in a large cohort of bladder cancers with substantial squamous differentiation comprising MIX-SCC (n = 50) and pure SCC (n = 75) (Table 1). This evidence concerns the gene ERBB2 and urinary bladder cancer.